Susquehanna Fundamental Investments’s Immunocore IMCR Stock Holding History

Susquehanna Fundamental Investments’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$541K	Buy	+17,039	New	+$504K	0.01%	549

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Susquehanna Fundamental Investments's IMCR Position: Q2 2026 in Review

Susquehanna Fundamental Investments opened a new position in Immunocore (IMCR) in Q2 2026: 17,039 shares worth $541K. The stake represents 0.01% of the portfolio and ranks #549 among its holdings.

136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Susquehanna Fundamental Investments held 17,039 shares of Immunocore worth $541K as of Q2 2026.
Immunocore was a new Susquehanna Fundamental Investments position in Q2 2026.
Immunocore made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q2 2026, its #549 holding.
136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2026, filed 14 Aug 2026.